DESCRIPTION | MEAN VALUE | UNCERTAINTY INTERVAL | SOURCE | PROBABILITY DISTRIBUTION |
---|---|---|---|---|
Epidemiological & treatment parameters | ||||
Prevalence of LTBI at entry | Varying* | – | – | |
Sensitivity of IGRA | 0.800 | 0.750–0.840 | [31] | beta |
Specificity of IGRA | 0.980 | 0.870–0.990 | [32] | beta |
Probability of TPT initiation | 0.700 | 0.600–0.800 | uniform | |
Probability of TPT completion | 0.700 | 0.600–0.800 | [33] | uniform |
Probability of reactivation of untreated LTBI | 0.053 | 0.025–0.080 | uniform | |
Effectiveness of complete TPT | 0.660 | 0.430–0.890 | [29] | uniform |
Effectiveness of incomplete TPT | 0.250 | 0.150–0.350 | Assumption | uniform |
Effectiveness of TPT for rifampicin-resistant LTBI | 0 | – | Assumption | – |
Probability of TPT drug-toxicity events not requiring hospitalization | 0.020 | 0.010–0.030 | beta | |
Probability of TPT drug-toxicity events requiring hospitalization | 0.0003 | 0.0001–0.0006 | [36] | beta |
Cost parameters | ||||
Cost for performing IGRA incl. Laboratory fees (€) | 47.03 | 37.62–56.43 | [37] | uniform |
Cost for counselling an IGRA-positive individual for TPT (€) | 27.34 | 21.87–32.80 | [37] | uniform |
Cost for physician consultation during TPT (fee for 2 quarters of a year; €) | 34.72 | 27.78–41.67 | [37] | uniform |
Cost for laboratory tests prior to and during TPT (€) | 16.18 | 12.95–19.42 | [37] | uniform |
Cost for 4-months of rifampicin-based TPT (€) | 330.39 | 322.91–337.87 | uniform | |
Factor for discounting cost for incomplete TPT | 0.375 | 0.250–0.500 | [35] | uniform |
In-patient management of drug adverse events of TPT (€) | 2553.10 | 1702.07 – 3404.13 | [39] | uniform |
Average costs for managing TB disease (€) | 8947.65 | 7158.12 - 10,737.17 | [37] | uniform |
Quality-of-life weights | ||||
Active TB | 0.67 | – | ||
LTBI | 1.00 | N/A | – | |
TPT-related drug toxicity not requiring hospitalization | 0.75 | – | ||
TPT-related drug toxicity requiring hospitalization | 0.50 | – | ||
Other parameters | ||||
Average age at immigration | 24 | [17] | – | |
Life expectancy at immigration (years) | 59 | Estimated from [48] | – | |
Average time to LTBI reactivation (years) | 7.0 | 6.0–8.0 | Estimated from [11] | uniform |
TB case-fatality ratio | 0.015 | 0.010–0.020 | Estimated from program data | uniform |